'Incredibly Exciting': Diabetes Drug With CV Benefits
The FDA's recent addition of a cardiovascular indication for diabetes drug empagliflozin is a significant milestone in diabetes care, says Dr Anne Peters.
'Incredibly Exciting': Diabetes Drug With CV Benefits
The FDA's recent addition of a cardiovascular indication for diabetes drug empagliflozin is a significant milestone in diabetes care, says Dr Anne Peters.